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Reduced Number of Hypocretin Clinical Study
Neurons in Human Narcolepsy
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Results and Discussion
The hypothalamus of 16 human brains, including fourSummary
narcoleptics and 12 neurologically normal individuals,
were immunostained for Hcrt. Three of the narcoleptic
Murine and canine narcolepsy can be caused by muta- brains had been in 10% formalin fixative for 4–5 years.
tions of the hypocretin (Hcrt) (orexin) precursor or Hcrt A fourth was moved from formalin to a sodium azide
receptor genes. In contrast to these animal models, solution shortly after fixation and remained refrigerated
most human narcolepsy is not familial, is discordant in this solution at 48 C for 12 years. We found that it was
in identical twins, and has not been linked to mutations necessary to use antigen retrieval techniques (Jiao et
of the Hcrt system. Thus, the cause of human narco- al., 1999) on all the narcoleptic brains to stain the Hcrt
lepsy remains unknown. Here we show that human neurons.
narcoleptics have an 85%–95% reduction in the num- To control for the time spent in fix, we processed three
ber of Hcrt neurons. Melanin-concentrating hormone neurologically normal brains that, like the narcoleptic
brains, had been held in fix in our laboratory for five or(MCH) neurons, which are intermixed with Hcrt cells in
more years and stained them with the same antibodiesthe normal brain, are not reduced in number, indicating
(Table 1). As in the narcoleptic brains, no Hcrt stainingthat cell loss is relatively specific for Hcrt neurons.
was apparent in these normal brains unless antigen re-The presence of gliosis in the hypocretin cell region
trieval techniques were used. An additional nine nonnar-is consistent with a degenerative process being the
coleptic human brains that had been in fix for 2 monthscause of the Hcrt cell loss in narcolepsy.
to 2 years were stained without the use of antigen re-
trieval.
Introduction Hypothalamic tissue from the brains of neurologically
normal individuals held in fix for up to 16 years and
Narcolepsy is an incurable, debilitating, neurological treated for antigen retrieval, and relatively fresh neuro-
disease characterized by sleep attacks, episodic loss logically normal tissue held in fix for less than 2 months
of muscle tone (cataplexy), hypnagogic hallucinations, and stained without antigen retrieval techniques showed
and abnormalities of the sleep–wake cycle. It was first the same pattern of Hcrt staining. There was no signifi-
described more than 120 years ago (Westphal, 1877; cant relation between time in fix and number of Hcrt
Fisher, 1878; Gelineau, 1880), but its cause is unknown. cells stained (p . 0.5, r 5 0.25, df 5 7). There was also
Recently, it was found that genetically narcoleptic dogs no significant correlation with the age (p . 0.2, r 5
have a mutation in the Hcrt receptor 2 gene (Lin et al., 20.60, t 5 21.29, df 5 3,) or sex (p . 0.25, t 5 1.2, df 5
1999). At about the same time, it was reported that mice 7) of the subjects (see Table 1).
with a null mutation of the preprohypocretin gene, which We found that the narcoleptic brains had a dramatic
produces Hcrt-1 and Hcrt-2, also show symptoms of loss of Hcrt cells. The number of Hcrt neurons in narco-
narcolepsy (Chemelli et al., 1999). These findings sug- leptics was reduced by between 85% and 95% percent
gest that malfunction of the Hcrt system may underlie from the number seen in controls (p , 0.000001, t 5
the syndrome of human narcolepsy. 10.9, df 5 11; Figures 1, 2, and 3).
Despite the difference in the number of Hcrt cells,
there was no marked difference in the number of mela-k To whom correspondence should be addressed (e-mail: jsiegel@
nin-concentrating hormone (MCH) neurons (Figure 4),ucla.edu).
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Figure 1. Distribution of Hypocretin-Labeled So-
mas in Normal and Narcoleptic Subjects
Normal is subject CG, and narcoleptic is subject
NA. Cell counts are listed below each section.
On average, the narcoleptics had only 7% of the
Hcrt cells seen in normals.
Figure 2. Distribution of Cells in Perifornical and Dorsomedial Hypothalamic Regions of
Normal and Narcoleptic Humans Plotted in Figure 1
All cells in figure are from the levels indicated in (A) and (B). (C and D) Low power photomi-
crographs (calibration [Cal.] 5 100 mm) covering regions outlined in gray at the top shows
many Hcrt somas and axons in the normal and few in the narcoleptic (arrows in narcoleptic
indicate Hcrt somas verified as immunolabeled at higher magnification). Higher power
photomicrographs (Cal. 5 25mm) show Hcrt cells and axons in normal (E and G) and
narcoleptic (F and H) subjects. Note the reduced density of axonal staining in the back-
ground of the narcoleptic as compared to that seen in the normal.
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(Moore et al., 2000). It has been hypothesized that a
reduction of Hcrt activation of the monoaminergic nuclei
of the brainstem may be responsible for the occurrence
of cataplexy and that a reduction in Hcrt activation of
cholinergic brainstem and basal forebrain neurons may
cause the sleepiness of narcolepsy (Siegel, 1999; Wu et
al., 1999). The loss of Hcrt neurons seen in the present
study is consistent with these hypotheses. The greatly
reduced numbers of Hcrt neurons can also explain the
reduced levels of Hcrt reported in the cerebrospinal fluid
of narcoleptics (Nishino et al., 2000). Hcrt neurons have
a dense projection to the suprachiasmatic nucleus
(Moore et al., 2000). The loss of this projection can ex-Figure 3. The Number of Hcrt Cells Is Decreased in Narcoleptics
plain the reduced amplitude of the circadian sleep
rhythm in narcoleptics, resulting in increased sleepiness
during the day and interrupted sleep at night (Guillemi-brain (Broberger et al., 1998). We counted MCH cells at
nault, 1994).their level of highest density (anterior mammillary nu-
The reduced numbers of Hcrt cells that we see in thecleus) in matched sections from four narcoleptics and
narcoleptics could result from a failure of the normalfour controls (Table 1). The number of MCH cells in the
developmental processes that produces these cells.narcoleptics (731 6 157) did not differ from the number
However, this hypothesis would not explain the relativelyin controls (734 6 119) (p . 0.9, t 5 1.1, df 5 7). Thus,
late and variable age of onset of the disorder. An alterna-the reduction in numbers of Hcrt neurons in narcoleptics
tive hypothesis is that neuronal degeneration causeswas not due to a nonspecific loss of hypothalamic cells
the cell loss. Recent studies in narcoleptic dogs reportedor a generalized loss of antigenicity in the tissue we
neuronal and axonal degeneration at the time of symp-tested. The significantly increased glial fibrillary acidic
tom onset (Siegel et al., 1999), although this degenera-protein (GFAP) labeling seen in the narcoleptic brains
tion does not cause a significant loss of Hcrt neuronsin comparison to controls (see below) is additional evi-
(Thannickal et al., 2000). We stained the hypothalamusdence of the preservation of antigenicity.
at the level of the mammillary bodies in the human narco-The antigen retrieval techniques that we have em-
leptic and control brains for GFAP and counted the num-ployed also do not contribute to the observed loss of
ber of astrocytes per square millimeter in the center ofHcrt cells. We were able to apply the same antigen
the hypothalamic Hcrt cell region, 2.3 mm lateral to theretrieval techniques to human brains that we had stored
ventricular surface, blind to the condition of the subjectsin the laboratory under identical conditions for the same
(Figures 5 and 6). The narcoleptics showed a signifi-or greater amounts of time. Antigen retrieval is thought
cantly higher number of labeled astrocytes comparedto act by reversing the protein cross-linking and protein
to controls (p , 0.001, t 5 6.4, df 5 7) (Figure 6). Thedenaturation that occurs with aldehyde-based fixation.
same comparison was made on the anterior thalamicAntigen retrieval by this technique produces a progres-
nucleus, just dorsal to the Hcrt region, 2.5 cm dorsal tosive increase in the intensity of staining in labeled cells
the base of the brain, and 2.3 mm from the lateral ventri-from below detectable levels in “overfixed” tissue to
cle. The thalamus has no Hcrt cells (Peyron et al., 1998).readily observable levels. More extended treatment
There was no significant difference between the leveldoes not alter the number of cells labeled but will cause
of gliosis in the narcoleptics and controls in the thalamusdisintegration of the tissue (Jiao et al., 1999). As was
(p . 0.2, t 5 1.5, df 5 7) (Figure 6). These observationsthe case with the narcoleptic brains, Hcrt staining was
and a prior case report of hypothalamic gliosis in annot visible in the untreated normal brains. However, with
idiopathic narcoleptic (Erlich and Itabashi, 1986) supportantigen retrieval treatment under conditions identical to
the neuronal degeneration hypothesis.those applied to the narcoleptic tissue, these brains had
Human narcolepsy has been shown to be linked tonormal numbers of labeled Hcrt neurons, whereas the
the presence of the HLA-DR2 or HLA-DQB1*0602, withnarcoleptics did not.
85%–95% of narcoleptics possessing this HLA haplo-Hcrt neurons in humans have dense projections to
locus coeruleus, raphe nuclei, and basal forebrain type (Honda et al., 1984; Mignot, 1998). However, more
Figure 4. Melanin-Concentrating Hormone
Neurons in Normal and Narcoleptic Subjects
Normal is subject CK, and narcoleptic is sub-
ject NA. Narcoleptics have normal numbers
of MCH neurons despite the loss of 93% of
Hcrt cells in the same region. Cal. 5 250 mm.
Neuron
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Figure 6. Pattern of Gliosis in the Hypothalamus and Thalamus of
Narcoleptics and Controls
The number of GFAP labeled astrocytes is significantly increased
in the hypothalamus of narcoleptics, the region containing Hcrt cells,
but not in the thalamus.
et al., 1988; Olerup et al., 1990). It is known that HLA
haplotypes are linked to a number of autoimmune dis-
eases including multiple sclerosis, insulin-dependent
diabetes, rheumatoid arthritis, Graves’ disease, myas-
thenia gravis, and systemic lupus erythematosus (Stroh-Figure 5. Glial Fibrillary Acidic Protein–Labeled Astrocytes in the Peri-
maier et al., 1988; Olerup et al., 1990). This has led toventricular/Perifornical Region of a Normal and Narcoleptic Brain
much speculation that narcolepsy is an autoimmuneLow power photomicrograph is at the top, and a higher magnification
disorder. However, no clear evidence for immune activa-of area marked with plus signs is at the bottom. Elevated GFAP staining
tion or for a target of immune activity has yet been foundin the hypothalamus of narcoleptics is consistent with a degenerative
in several studies of human narcoleptics (Fogdell et al.,cause of cell loss. Top, Cal. 5 500 mm; bottom, Cal. 5 50 mm.
1995; Hinze-Selch et al., 1998). The cause of the Hcrt
cell loss we observe remains to be determined. An as
than 30% of the general population has this same ge- yet uncharacterized autoimmune attack on Hcrt neurons
netic marker. DNA sequencing has not revealed any or a sensitivity of Hcrt cells to specific environmental or
biological toxins are reasonable possibilities.mutations in the HLA region in narcoleptics (Strohmaier
Table 1. Characteristics of the Subjects, Treatment of Hypothalamic Tissue, and Characteristics of Hcrt Cells
Hypothalmic Thalamic
Time in Gliosis Gliosis Number of Disease
Subject Sex Age Cause of Death Antibody Fix (Years) (Cells/mm2) (Cells/mm2) Hcrt Cells Onset Age Medications Cataplexy
Narcoleptics
NA F 63 adenocarcinoma 3 5 25.5 3.4 4,272 20 clomipramine Vivalan 1
NB M 49 cv 2 4.5 27.2 5.9 3,073 18 Dexedrine, Vivactil, GHB 1
NC M 60 sepsis 1 4.2 27.2 5.9 6,795 23 Ritalin Desoxyn 1
ND M 86 pulmonary 2 12 17.0 5.1 9,698 35 Ritalin 2
Controls
CA M 41 cv, HIV 1 1 79,575
CB F 54 liver failure 1 0.5 61,050
CC F 42 AML/DIC 1 1 8.5 0 73,424
CD M n/a nonneurol 1 2 0.0 3.4 83,121
CE M 73 pulmonary, cv 1 5 6.8 4.3 n/a
CF M n/a nonneurol 1 16 72,950
CG M n/a nonneurol 3 16 77,727
CH M 38 lung cancer 1 2 8.5 2.6 n/a
CI F 29 nonneurol 1 2 0.9 5.9 n/a
CJ M n/a nonneurol 3 2 72,457
CK F 83 Alzheimer’s 3 0.2 56,000
CL M 50 sepsis 3 4 50,576
cv, cardiovascular; AML, acute myelocytic leukemia; DIC, disseminated intravascular coagulation. “nonneurol” indicates no history of neurological illness
and no specified cause of death. Note that the elderly nonnarcoleptic Alzheimer’s patient whose brain we analyzed (subject CK) had a relatively preserved
Hcrt neuronal population, in contrast to the 85%–95% loss of Hcrt neurons seen in all of the narcoleptics, including one as young as 49 (subject NB).
The hypothalamus was not completely available in CE, CH, and CI, so the total numbers of Hcrt neurons could not be determined. Antibodies 1 and 2
indicate Hcrt-1 and -2 antibodies from Oncogene Research Products; 3 refers to a polyclonal antiserum raised against a synthetic hypocretin-2.
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Hcrt containing regions of the hypothalamus. We used a NikonThe loss of Hcrt cells in human narcoleptics suggests
E600 microscope with three axis motorized stage, video camera,that the replacement of the missing hypocretins may
Neurolucida interface, and Stereoinvestigator software (Micro-reverse some of the symptoms of this disease. A recent
Brightfield Corp., Colchester, Vermont). The optical fractionatorstudy in narcoleptic dogs demonstrated that intrave-
method was used. A “counting brick” of 600 3 500 3 20 mm was
nous administration of Hcrt-1 produces a rapid reversal employed. Cells in 30 randomly selected sites within the outlined
of narcoleptic symptomatology, with increased activity hypothalamic area of interest were counted within each slide. Only
levels, reduction or elimination of cataplexy, reduction cells whose tops came into focus as the microscope objective was
of sleepiness during the daytime, and consolidation of lowered through the brick were counted. Cells that extended across
the left or bottom boundary of the counting brick were excluded.sleep periods at night (John et al., 2000). Administration
Pilot studies of a normal and a narcoleptic human brain determinedof hypocretins or their agonists to human narcoleptics
that these parameters would produce a total count of at least 300may be an effective treatment for this disorder.
cells per brain and that the coefficient of error would be less than
0.08, well within the parameters required for accurate stereologyExperimental Procedures
(Howard and Reed, 1998).
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